Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06450353 · ClinicalTrials.gov registry record
Prospective Evaluation of Disparities in Provision of Allogeneic Transplantation
A clinical trial of Allogeneic Transplantation, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- 1,200
- Enrollment target
- 1
- Study location
NCT06450353 is a study of Allogeneic Transplantation that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 1,200 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06450353, a study of Allogeneic Transplantation, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- 1,200 participants
- Enrollment target
- 1
- Study location
Study Summary
To look at the effect of a recipient's ancestry and socio-economic status on their choice of bone marrow transplantation donor cells and their chance of receiving genetically similar (allogeneic) bone marrow cells versus cells that are not genetically similar (allograft).
Conditions Studied
Interventions
- BEHAVIORAL Patient Ancestry Questionnaires
Study Locations (1)
Texas
- MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,200 participants |
| Start Date | 2024-05-31 |
| Est. Completion | 2029-06-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06450353
The ClinicalTrials.gov registry entry for NCT06450353 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Allogeneic Transplantation appearing as the primary indexed condition, and to 1 intervention - of which Patient Ancestry Questionnaires is the first listed.
NCT06450353 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT06450353 about?
NCT06450353 is a clinical study titled "Prospective Evaluation of Disparities in Provision of Allogeneic Transplantation". To look at the effect of a recipient's ancestry and socio-economic status on their choice of bone marrow transplantation donor cells and their chance of receiving genetically similar (allogeneic) bone marrow cells versus cells that are not genetically similar (allograft).
What is the current status of trial NCT06450353?
This trial is currently recruiting. The enrollment target is 1,200 participants. The study started on 2024-05-31. Estimated completion is 2029-06-01.
What conditions does trial NCT06450353 study?
This clinical trial studies the following conditions: Allogeneic Transplantation.
What interventions are being tested in trial NCT06450353?
The interventions under investigation include: Patient Ancestry Questionnaires (BEHAVIORAL).
Who is sponsoring clinical trial NCT06450353?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06450353 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Allogeneic Transplantation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.